Clinical Trials Logo

Clinical Trial Summary

The aim of the study is to estimate the impact of the protein content of breastmilk at the end of hospitalization of the preterm newborn, on the neurodevelopment at 2 years old. The investigators expect a difference of at least 5 points of Development Quotient (DQ) when comparing extreme terciles of the protein content of breastmilk at the end of hospitalization.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01493063
Study type Observational
Source Nantes University Hospital
Contact
Status Active, not recruiting
Phase
Start date October 25, 2011
Completion date September 2025

See also
  Status Clinical Trial Phase
Completed NCT00817921 - Effect of Prematurity on Renal Function in 5 Years Old Children N/A
Not yet recruiting NCT01305720 - The Effect of Mydriatic Eye Drops on Cerebral and Mesenteric Oxygenation in Preterm Infants Phase 4
Completed NCT01300130 - Investigations on Improving Docosahexaenoic and Arachidonic Acid Content in Preterm Infant Formula N/A
Active, not recruiting NCT01517828 - Intranasal Midazolam Versus Intranasal Ketamine to Sedate Newborns for Intubation in Delivery Room Phase 3
Completed NCT01388439 - Pharmacokinetics of Oseltamivir in Newborns and Infants N/A
Completed NCT01428180 - Influence of Treatment for Patent Ductus Arteriosus on Cerebral Oxygenation in Preterm Infants Phase 4
Completed NCT01367015 - Early Versus Late Initiation of Feeding in Premature Growth Restricted Newborns With Absent or Reversed End Diastolic Flow On Umbilical Artery Doppler (AREDF) N/A